Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins

American tegumentary leishmaniasis (TL) caused by Leishmania braziliensis is characterized by a spectrum of clinical presentations, ranging from localized cutaneous ulcers (CL), mucosal (ML), or disseminated (DL) disease, to a subclinical (SC) asymptomatic form. Current diagnosis based on parasite c...

Full description

Bibliographic Details
Main Authors: Sayonara M. Viana, Alba L. Montoya, Augusto M. Carvalho, Brunele S. de Mendonça, Susana Portillo, Janet J. Olivas, Nasim H. Karimi, Igor L. Estevao, Uriel Ortega-Rodriguez, Edgar M. Carvalho, Walderez O. Dutra, Rosa A. Maldonaldo, Katja Michael, Camila I. de Oliveira, Igor C. Almeida
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
Leishmania braziliensis
tegumentary leishmaniasis
diagnostic and prognostic biomarkers
α-Gal neoglycoproteins
anti-α-Gal antibodies
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2114852

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2114852

Similar Items